RE:INVESTORS ARENT BUYING IT YETI would rather if TLT would concentrate on NMIBC which is so close to BTD or even apply for FDA approval once 85 patients are treated and results presented. Investors are wary about TLT approach of multi directional/multi application approach without any meaningful solution to raising capital. We have all seen them struggling with PP and PP with the same results. Existing Investors are reluctant to jump into a penny stock inspite of the tall claims.
If the management opt to concentrate on NMIBC and get the nod from FDA, There would be a huge shift in credibility which is a major issue now. I would think more new investors would be drawn in. This would in my opiniion raise the stock price considerably may be to $1 to $ 5 level. TLT would have the option to move from the venture exchange to TSX and NASDAQ, After this who knows, RDW would be in-undated by calls from Major Pharma for a JV and Acquisition offers!!. RDW would be able to negotiate from a position of strength and raising capital would not be an issue at all.
My sincere hope is that TLT would keep their EYE on the End Game for NMIBC instead of trying to diversify and causing more distraction than any meaningful solution to raising capital.
I have been a long time believer and investor with substantial stake in the company. I simply decided exactly a year ago to step aside and observe instead of buying. I have not sold yet, still believe TLT can and will SUCCEED!!